C86.51 Angioimmunoblastic T-cell lymphoma, in remission
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C86.51.
The ICD-10-CM code for Angioimmunoblastic T-cell lymphoma, in remission is C86.51 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Chapter
- 2: Neoplasms (C00-D49)
- Section
- C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
- Category C86
- 22 codes (14 billable)
- FY2026 Status
- Introduced in FY2025
Inclusion Terms
- Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), in remission
Official Coding Guidelines
Tx of primary site (TOC entry)a. Admission/Encounter for treatment of primary site ............................................................. 33
Tx of secondary site (TOC entry)b. Admission/Encounter for treatment of secondary site .......................................................... 33
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference C86.51 with the canonical source and edition:
C86.51 — Angioimmunoblastic T-cell lymphoma, in remission. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C86.51
Canonical URL: https://icd10codingpro.com/codes/C86.51